Wenchao C. Zhao

Taizhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: November 29, 2025

TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer.

TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer.

Journal: Dose-response : a publication of International Hormesis Society

Published: September 12, 2025

LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1.

LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1.

Journal: Biochemical pharmacology

Published: August 14, 2025

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Journal: Journal of medicinal chemistry

Published: June 06, 2025

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD.

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD.

Journal: Archives of pharmacal research

Published: May 22, 2025

Multifunctional terahertz metamaterials device based on a dual-tunable structure incorporating graphene and vanadium oxide.

Multifunctional terahertz metamaterials device based on a dual-tunable structure incorporating graphene and vanadium oxide.

Journal: Nanoscale advances

Published: March 26, 2025

An Angle- and Polarization-Selective Dual-Wavelength Narrowband Thermal Emitter for Infrared Multilevel Encryption.

An Angle- and Polarization-Selective Dual-Wavelength Narrowband Thermal Emitter for Infrared Multilevel Encryption.

Journal: Research (Washington, D.C.)

Published: March 19, 2025

Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: February 13, 2025

Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease.

Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease.

Journal: Biochemical pharmacology

Published: February 12, 2025

Prostate cancer and metabolic syndrome: exploring shared signature genes through integrative analysis of bioinformatics and clinical data.

Prostate cancer and metabolic syndrome: exploring shared signature genes through integrative analysis of bioinformatics and clinical data.

Journal: Discover oncology

Published: May 14, 2024

A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.

A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.

Journal: Journal of the American Society of Nephrology : JASN

Published: May 01, 2024

Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease.

Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of medicinal chemistry

Published: March 20, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026